Abstract
Ten healthy male volunteers were given 200 mg p.o. of isoxicam after an overnight fast and the plasma concentrations over time followed for 96 h by h.p.l.c. Five days later enteric coated acetylsalicylic acid (ASA) 650 mg four times daily was started and continued for 10 days producing steady state trough plasma salicylate of 83 mg/l (range 21-133). A second 200 mg isoxicam dose was given 5 days after starting ASA and the plasma concentration time-curve again followed. After ASA, there was no change in lag time (0.54 vs 0.51 h), time to peak concentration (10 vs 10 h), or disappearance t1/2 (28.7 vs 31.0 h) however the peak isoxicam concentration and AUC were reduced 18 and 22% respectively (P less than 0.01). Plasma protein binding of isoxicam studied by equilibrium dialysis was 96 +/- 1% in the absence and 86 +/- 5% in the presence of ASA. The reduction in binding was unrelated to plasma SA concentrations achieved or observed reductions in AUC for plasma isoxicam. ASA decreased plasma isoxicam binding, peak plasma isoxicam concentrations and AUC without altering the apparent disappearance half-life of total plasma isoxicam after a single oral dose.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Brooks P. M., Walker J. J., Bell M. A., Buchanan W. W., Rhymer A. R. Indomethacin--aspirin interaction: a clinical appraisal. Br Med J. 1975 Jul 12;3(5975):69–71. doi: 10.1136/bmj.3.5975.69. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Champion G. D., Paulus H. E., Mongan E., Okun R., Pearson C. M. The effect of aspirin on serum indomethacin. Clin Pharmacol Ther. 1972 Mar-Apr;13(2):239–244. doi: 10.1002/cpt1972132239. [DOI] [PubMed] [Google Scholar]
- Fowler P. D. Diclofenac sodium (Voltarol): drug interactions and special studies. Rheumatol Rehabil. 1979;Suppl 2:60–68. [PubMed] [Google Scholar]
- Grennan D. M., Ferry D. G., Ashworth M. E., Kenny R. E., Mackinnon M. The aspirin-ibuprofen interaction in rheumatoid arthritis. Br J Clin Pharmacol. 1979 Nov;8(5):497–503. doi: 10.1111/j.1365-2125.1979.tb01033.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hobbs D. C., Twomey T. M. Piroxicam pharmacokinetics in man: aspirin and antacid interaction studies. J Clin Pharmacol. 1979 May-Jun;19(5-6):270–281. doi: 10.1002/j.1552-4604.1979.tb02480.x. [DOI] [PubMed] [Google Scholar]
- Jeremy R., Towson J. Interaction between aspirin and indomethacin in the treatment of rheumatoid arthritis. Med J Aust. 1970 Jul 18;2(3):127–129. doi: 10.5694/j.1326-5377.1970.tb87342.x. [DOI] [PubMed] [Google Scholar]
- Montgomery P. R., Sitar D. S. Increased serum salicylate metabolites with age in patients receiving chronic acetylsalicylic acid therapy. Gerontology. 1981;27(6):329–333. doi: 10.1159/000212493. [DOI] [PubMed] [Google Scholar]
- Rubin A., Rodda B. E., Warrick P., Gruber C. M., Jr, Ridolfo A. S. Interactions of aspirin with nonsteroidal antiinflammatory drugs in man. Arthritis Rheum. 1973 Sep-Oct;16(5):635–645. doi: 10.1002/art.1780160508. [DOI] [PubMed] [Google Scholar]
- Segre E. J., Chaplin M., Forchielli E., Runkel R., Sevelius H. Naproxen-aspirin interactions in man. Clin Pharmacol Ther. 1974 Apr;15(4):374–379. doi: 10.1002/cpt1974154374. [DOI] [PubMed] [Google Scholar]
- Williams R. L., Upton R. A., Buskin J. N., Jones R. M. Ketoprofen-aspirin interactions. Clin Pharmacol Ther. 1981 Aug;30(2):226–231. doi: 10.1038/clpt.1981.152. [DOI] [PubMed] [Google Scholar]
- Willkens R. F., Segre E. J. Combination therapy with naproxen and aspirin in rheumatoid arthritis. Arthritis Rheum. 1976 Jul-Aug;19(4):677–682. doi: 10.1002/1529-0131(197607/08)19:4<677::aid-art1780190404>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]